Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

๐€๐’๐‚๐Ž ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: Bicara Therapeutics is presenting long-term follow up data at ASCO that it believes shows durability derived from choosing TGF-ฮฒ with EGFR for its fusion protein in HPV negative head & neck. $BCAX #ASCO26 Full video:

BiotechTV's profile picture

BiotechTV

11,755 subscribers

11,479 Aufrufe โ€ข vor 2 Monaten โ€ขvia X (Twitter)

#ASCO26
LIVE

Anya Rossiโ€ข Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfรผgbar

Kommentare vom Original-Post werden hier angezeigt

ร„hnliche Videos

๐€๐’๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“: KeloniaTx presented convincing late-breaking data at ASH today from its initial patients in multiple myeloma suggesting that in vivo CAR-T is on track to be a next innovation. Full video:
4:43

๐€๐’๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“: KeloniaTx presented convincing late-breaking data at ASH today from its initial patients in multiple myeloma suggesting that in vivo CAR-T is on track to be a next innovation. Full video:

BiotechTV

21,941 Aufrufe โ€ข vor 8 Monaten

Big deals and small molecules with Nimbus Therapeutics CEO Jeb Keiper. Full video:
2:24

Big deals and small molecules with Nimbus Therapeutics CEO Jeb Keiper. Full video:

BiotechTV

29,583 Aufrufe โ€ข vor 3 Jahren

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib. $CRVS Full video:
4:58

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Corvus Pharma CEO Richard Miller fields follow-up questions about last week's atopic dermatitis data for the ITK inhibitor soquelitinib. $CRVS Full video:

BiotechTV

24,695 Aufrufe โ€ข vor 6 Monaten

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:
3:01

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Abivax CEO Marc de Garidel discusses freshly released maintenance part 2 results for obefazimod in UC and describes how he believes it builds on initial data announced earlier this month. $ABVX Watch the full video:

BiotechTV

22,305 Aufrufe โ€ข vor 1 Monat

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: After switching to a new GalNAc-LNP delivery vehicle a year ago, @VerveTx today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor. Co-Founder & CEO Sek Kathiresan MD covers the data. $VERV Full video:
5:19

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: After switching to a new GalNAc-LNP delivery vehicle a year ago, @VerveTx today announced the initial safety and efficacy data from its VERVE-102 PCSK9 based editor. Co-Founder & CEO Sek Kathiresan MD covers the data. $VERV Full video:

BiotechTV

22,484 Aufrufe โ€ข vor 1 Jahr

๐…๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐๐š๐ฒ ๐€๐ซ๐ž๐š: Gordian Biotechnology announced that it will be using its unique large-scale in vivo screening process to help Pfizer look for new targets against obesity. Co Founder & CSO Martin Borch Jensen explains how it works. Full video:
2:56

๐…๐ซ๐จ๐ฆ ๐ญ๐ก๐ž ๐๐š๐ฒ ๐€๐ซ๐ž๐š: Gordian Biotechnology announced that it will be using its unique large-scale in vivo screening process to help Pfizer look for new targets against obesity. Co Founder & CSO Martin Borch Jensen explains how it works. Full video:

BiotechTV

13,213 Aufrufe โ€ข vor 6 Monaten

๐…๐ซ๐จ๐ฆ ๐’๐ž๐จ๐ฎ๐ฅ: Daejeon based Orum Therapeutics is pioneering the field of degrader-antibody conjugates. Founder SJ Lee describes the science and gives us an overview of biotech in Korea. Full video:
4:12

๐…๐ซ๐จ๐ฆ ๐’๐ž๐จ๐ฎ๐ฅ: Daejeon based Orum Therapeutics is pioneering the field of degrader-antibody conjugates. Founder SJ Lee describes the science and gives us an overview of biotech in Korea. Full video:

BiotechTV

15,588 Aufrufe โ€ข vor 1 Jahr

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:
3:36

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: With three approved products and filings for more over the near term, Axsome Therapeutics's CEO describes the scale and reach this company is building in the CNS space. $AXSM Full video:

BiotechTV

20,894 Aufrufe โ€ข vor 1 Jahr

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Olema Oncology more than doubled yesterday when Roche announced surprise data for its oral SERD - the CEO reacts and shares the development program for Olema's competing asset. $OLEM Full video:
4:00

๐‰๐ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ž๐ฌ ๐‹๐จ๐ง๐๐จ๐ง: Olema Oncology more than doubled yesterday when Roche announced surprise data for its oral SERD - the CEO reacts and shares the development program for Olema's competing asset. $OLEM Full video:

BiotechTV

12,936 Aufrufe โ€ข vor 9 Monaten

๐๐ซ๐ข๐ ๐ก๐ญ ๐Œ๐ข๐ง๐๐ฌ: William Blair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron. $VKTX $LLY Full video:
13:02

๐๐ซ๐ข๐ ๐ก๐ญ ๐Œ๐ข๐ง๐๐ฌ: William Blair Senior Biotech Analyst Andy Hsieh reacts to today's oral obesity data from Viking's VK2735 and recent data from Lilly's orforglipron. $VKTX $LLY Full video:

BiotechTV

68,717 Aufrufe โ€ข vor 1 Jahr

๐“๐ก๐ž ๐’๐ญ๐ฎ๐๐ข๐จ ๐š๐ญ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ ๐’๐ช๐ฎ๐š๐ซ๐ž: Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP. Full video:
7:30

๐“๐ก๐ž ๐’๐ญ๐ฎ๐๐ข๐จ ๐š๐ญ ๐Š๐ž๐ง๐๐š๐ฅ๐ฅ ๐’๐ช๐ฎ๐š๐ซ๐ž: Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP. Full video:

BiotechTV

11,800 Aufrufe โ€ข vor 1 Jahr

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Renowned scientist and entrepreneur Greg Verdine announced $263M in new funding for his company LifeMine Therapeutics. Participating investors include names like Bezos and Gates. See the full interview:
1:54

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Renowned scientist and entrepreneur Greg Verdine announced $263M in new funding for his company LifeMine Therapeutics. Participating investors include names like Bezos and Gates. See the full interview:

BiotechTV

20,050 Aufrufe โ€ข vor 13 Tagen

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year. $ABVX Full video:
3:51

๐’๐… ๐‡๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐–๐ž๐ž๐ค: Abivax CEO Marc de Garidel reflects on a breakout 2025 for obefazimod and key data that will read out this year. $ABVX Full video:

BiotechTV

73,893 Aufrufe โ€ข vor 7 Monaten

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:
6:11

๐Ž๐Ÿ๐Ÿ-๐“๐š๐ซ๐ ๐ž๐ญ ๐„๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ฌ: BridgeBio Pharma Founder & CEO Neil Kumar and Roivant Sciences CEO Matt Gline discusses the hub and spoke biotech model and trying to build a sustainable business for the long-term. $BBIO $ROIV Watch the full episode:

BiotechTV

11,639 Aufrufe โ€ข vor 3 Monaten

๐€๐’๐†๐‚๐“ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: Michael Torres isn't slowing down after selling his antibody-drug conjugate company to Eli Lilly. Here's his gene therapy play. Full video:
4:45

๐€๐’๐†๐‚๐“ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”: Michael Torres isn't slowing down after selling his antibody-drug conjugate company to Eli Lilly. Here's his gene therapy play. Full video:

BiotechTV

10,996,973 Aufrufe โ€ข vor 3 Monaten

๐Ÿšจ BITCOIN LOOKS WEAK BUT ITS COILING Bitcoin feels heavy. ETFs saw over $450M flow out. Fear is at 15. Long term holders are rotating and new participants are exiting. It looks ugly but these patterns show up near cycle bottoms. The market is quietly resetting for the next phase. Watch the full video in the comments.
2:34

๐Ÿšจ BITCOIN LOOKS WEAK BUT ITS COILING Bitcoin feels heavy. ETFs saw over $450M flow out. Fear is at 15. Long term holders are rotating and new participants are exiting. It looks ugly but these patterns show up near cycle bottoms. The market is quietly resetting for the next phase. Watch the full video in the comments.

Kyle Chassรฉ ๐Ÿธ

105,603 Aufrufe โ€ข vor 9 Monaten

๐€๐’๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“: Checking in (quickly) with Terns Pharmaceuticals CEO Amy Burroughs on the tern-701 data at ASH. $TERN
5:58

๐€๐’๐‡ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ“: Checking in (quickly) with Terns Pharmaceuticals CEO Amy Burroughs on the tern-701 data at ASH. $TERN

BiotechTV

18,704 Aufrufe โ€ข vor 8 Monaten

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Aerska launched in the UK today with $21M in financing to develop RNAi medicines for neurological conditions that are delivered to the brain via 'brain shuttle' technologies. CEO Jack O'Meara explains. Full video:
4:35

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Aerska launched in the UK today with $21M in financing to develop RNAi medicines for neurological conditions that are delivered to the brain via 'brain shuttle' technologies. CEO Jack O'Meara explains. Full video:

BiotechTV

19,198 Aufrufe โ€ข vor 10 Monaten

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Solid Biosciences's CEO Bo Cumbo discusses today's data release of the company's microdystrophin gene therapy candidate for Duchenne muscular dystrophy. $SLDB Full video:
7:29

๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ฒ ๐๐ž๐ฐ๐ฌ: Solid Biosciences's CEO Bo Cumbo discusses today's data release of the company's microdystrophin gene therapy candidate for Duchenne muscular dystrophy. $SLDB Full video:

BiotechTV

42,139 Aufrufe โ€ข vor 1 Jahr